Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 2
2005 1
2006 6
2007 3
2008 2
2009 6
2010 10
2011 6
2012 5
2013 6
2014 6
2015 6
2016 8
2017 5
2018 7
2019 7
2020 11
2021 18
2022 23
2023 18
2024 12
2025 20
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study.
Ruscitti P, Stamm T, Ritschl V, Mitrovic S, Girard-Guyonvarc'h C, Atzeni F, Bostrøm C, Cantarini L, Caso F, Cipriani P, Ciccia F, Gattorno M, Guggino G, Guillemin F, Krusche M, Llorca J, Montecucco C, Perosa F, Quartier P, Ravelli A, Rosine N, Wieczorek M, Wilhelmer TC, Gonzalez-Gay MÁ, Gabay C, Fautrel B, Feist E, Giacomelli R; CONSIDER trial study group; GIRRCS-AOSD research group. Ruscitti P, et al. Among authors: feist e. Lancet Rheumatol. 2026 Mar 25:S2665-9913(25)00377-7. doi: 10.1016/S2665-9913(25)00377-7. Online ahead of print. Lancet Rheumatol. 2026. PMID: 41903559
Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study.
Östör A, Feist E, Sidiropoulos P, Avouac J, Rebella M, Namas R, Buttgereit F, Conaghan PG, Romero AB, McDearmon-Blondell EL, Lagunes-Galindo I, Gao T, Kadakia A, Shaw T, Attar S. Östör A, et al. Among authors: feist e. Rheumatol Ther. 2026 Mar 19. doi: 10.1007/s40744-026-00826-5. Online ahead of print. Rheumatol Ther. 2026. PMID: 41854829 Free article.
[Autoinflammatory syndromes].
Satirer Ö, Feist E, Satirer Y, Kuemmerle-Deschner J. Satirer Ö, et al. Among authors: feist e. Dtsch Med Wochenschr. 2026 Jan;151(1-02):47-65. doi: 10.1055/a-2337-4272. Epub 2025 Dec 10. Dtsch Med Wochenschr. 2026. PMID: 41371246 Review. German.
[Flexible working time models in rheumatology : Results of a Germany-wide survey].
Pecher AC, Albrecht K, Baraliakos X, Callhoff J, Feist E, Haase I, Koehm M, Krusche M, Sewerin P, Voormann A, Ohrndorf S, Mucke J; Kommission für Chancengleichheit der Deutschen Gesellschaft für Rheumatologie und Klinische Immunologie. Pecher AC, et al. Among authors: feist e. Z Rheumatol. 2025 Dec 8. doi: 10.1007/s00393-025-01761-6. Online ahead of print. Z Rheumatol. 2025. PMID: 41359043 German.
[Erratum to: Innovative treatments in rheumatology].
Singla A, Iking-Konert C, Kellersmann C, Mougiakakos D, Feist E. Singla A, et al. Among authors: feist e. Z Rheumatol. 2025 Sep;84(7):591-594. doi: 10.1007/s00393-025-01694-0. Z Rheumatol. 2025. PMID: 40824445 German. No abstract available.
174 results